Mark Baldry X4 Pharmaceuticals, Inc (XFOR) insider trading activity

Mark Baldry is Chief Commercial Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 729,173 shares of XFOR, which is worth approximately $342,711. The most recent transaction as insider was on Feb 12, 2025, when has been sold 600,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 729K

464.49% 3M change

2853.31% 12M change

Total Value Held $342,711

Mark Baldry Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2025	BUY Grant, award, or other acquisition	-	600,000 Added 45.14%	729,173 Common Stock
Jan 24 2025	SELL Open market or private sale	$13,121 $0.45 p/Share	29,159 Reduced 23.65%	94,123 Common Stock
Jan 23 2025	BUY Grant, award, or other acquisition	-	74,773 Added 37.75%	123,282 Common Stock
Nov 15 2024	BUY Open market or private purchase	$4,557 $0.34 p/Share	13,404 Added 9.4%	129,173 Common Stock
Oct 07 2024	SELL Open market or private sale	$6,453 $0.58 p/Share	11,127 Reduced 18.66%	48,509 Common Stock
Oct 04 2024	BUY Grant, award, or other acquisition	-	34,946 Added 36.95%	59,636 Common Stock
May 17 2024	BUY Open market or private purchase	$14,719 $0.68 p/Share	21,646 Added 15.75%	115,769 Common Stock
Nov 01 2023	SELL Open market or private sale	$7,487 $0.73 p/Share	10,257 Reduced 29.35%	24,690 Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	-	34,947 Added 50.0%	34,947 Common Stock

Mark Baldry

Chief Commercial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Value

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to X4 Pharmaceuticals, Inc

Track Activities on XFOR

Account